|
1.Stauffer JL, Fayter NA, Graves B, Cromb M, Lynch JC, Goebel P, (1993) Survival following mechanical ventilation for acute respiratory failure in adult men. Chest 104: 1222-1229 2.Daly BJ, Rudy EB, Thompson KS, Happ MB, (1991) Development of a special care unit for chronically critically ill patients. Heart Lung 20: 45-51 3.Lemaire F, (1993) Difficult weaning. Intensive Care Med 19 Suppl 2: S69-73 4.Carson SS, Bach PB, Brzozowski L, Leff A, (1999) Outcomes after long-term acute care. An analysis of 133 mechanically ventilated patients. Am J Respir Crit Care Med 159: 1568-1573 5.Wagner DP, (1989) Economics of prolonged mechanical ventilation. Am Rev Respir Dis 140: S14-18 6.Ely EW, Meade MO, Haponik EF, Kollef MH, Cook DJ, Guyatt GH, Stoller JK, (2001) Mechanical ventilator weaning protocols driven by nonphysician health-care professionals: evidence-based clinical practice guidelines. Chest 120: 454S-463S 7.MacIntyre NR, (2002) Bringing scientific evidence to the ventilator weaning and discontinuation process: evidence-based practice guidelines. Respir Care 47: 29-30 8.MacIntyre NR, Cook DJ, Ely EW, Jr., Epstein SK, Fink JB, Heffner JE, Hess D, Hubmayer RD, Scheinhorn DJ, (2001) Evidence-based guidelines for weaning and discontinuing ventilatory support: a collective task force facilitated by the American College of Chest Physicians; the American Association for Respiratory Care; and the American College of Critical Care Medicine. Chest 120: 375S-395S 9.Vincent JL, (2003) Nosocomial infections in adult intensive-care units. Lancet 361: 2068-2077 10.Klevens RM, Edwards JR, Tenover FC, McDonald LC, Horan T, Gaynes R, (2006) Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis 42: 389-391 11.Gaynes R, Edwards JR, (2005) Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 41: 848-854 12.Haley RW, Culver DH, White JW, Morgan WM, Emori TG, Munn VP, Hooton TM, (1985) The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 121: 182-205 13.Edmond MB WR (2005) Organization for infection control. In: GL M (ed) Mandell, Douglas, and Bennett’s Principles and practice of infectious diseases Churchill Livingstone, Philadelphia, pp. 3323-3325 14.Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM, (1988) CDC definitions for nosocomial infections, 1988. Am J Infect Control 16: 128-140 15.Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG, (1992) CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Am J Infect Control 20: 271-274 16.Emori TG, Culver DH, Horan TC, Jarvis WR, White JW, Olson DR, Banerjee S, Edwards JR, Martone WJ, Gaynes RP, et al., (1991) National nosocomial infections surveillance system (NNIS): description of surveillance methods. Am J Infect Control 19: 19-35 17.Shlaes DM, Gerding DN, John JF, Jr., Craig WA, Bornstein DL, Duncan RA, Eckman MR, Farrer WE, Greene WH, Lorian V, Levy S, McGowan JE, Jr., Paul SM, Ruskin J, Tenover FC, Watanakunakorn C, (1997) Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Infect Control Hosp Epidemiol 18: 275-291 18.Laplane R, Begue P, Bricout F, Lasfargues G, (1977) [Bacterial infections caused by multi-resistant organisms at the Hopital Trousseau in 1974. Incidence, origin and prevention]. Ann Med Interne (Paris) 128: 401-403 19.Wright MO, (2005) Multi-resistant gram-negative organisms in Maryland: a statewide survey of resistant Acinetobacter baumannii. Am J Infect Control 33: 419-421 20.Steinberg JP DRC (2000) Other gram-negative bacilli. In: GL M (ed) Mandell, Douglas, and Bennett’s Principles and practice of infectious diseases. Churchill Livingstone, Philadelphia, pp. 2459–2474 21.Horan TC GR (2004) Surveillance of nosocomial infections. In: CG M (ed) Hospital Epidemiology and Infection Control. Lippincott-Williams & Wilkins, Philadelphia, pp. 1659-1702 22.National Committee for Clinical and Laboratory Standards. Performance standards for antimicrobial susceptibility testing; 17th informational supplement (M100-S17). Wayne, PA: National Committee for Clinical and Laboratory Standards, 2007. 23.Seneff MG, Zimmerman JE, Knaus WA, Wagner DP, Draper EA, (1996) Predicting the duration of mechanical ventilation. The importance of disease and patient characteristics. Chest 110: 469-479 24.Gracey DR, Viggiano RW, Naessens JM, Hubmayr RD, Silverstein MD, Koenig GE, (1992) Outcomes of patients admitted to a chronic ventilator-dependent unit in an acute-care hospital. Mayo Clin Proc 67: 131-136 25.Scheinhorn DJ, Chao DC, Stearn-Hassenpflug M, LaBree LD, Heltsley DJ, (1997) Post-ICU mechanical ventilation: treatment of 1,123 patients at a regional weaning center. Chest 111: 1654-1659 26.Chang SC TC, Wang JT, et al., (2004) Nosocomial Infections in Medical Centers and Regional Hospitals between 1999 and 2002 in Taiwan. . Infect Control J 14: 1- 11 27.Freeman J TI (2004) Modern quantitative epidemiology in the hospital. In: CG M (ed) Hospital Epidemiology and Infection Control. Lippincott-Williams & Wilkins, Philadelphia, pp. 19-48 28.Su J, Lin CY, Chen PJ, Lin FJ, Chen SK, Kuo HT, (2006) Experience with a step-down respiratory care center at a tertiary referral medical center in Taiwan. J Crit Care 21: 156-161 29.Cook DJ, Walter SD, Cook RJ, Griffith LE, Guyatt GH, Leasa D, Jaeschke RZ, Brun-Buisson C, (1998) Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med 129: 433-440 30.Kollef MH, (2004) Prevention of hospital-associated pneumonia and ventilator-associated pneumonia. Crit Care Med 32: 1396-1405 31.Cavalcanti M, Ferrer M, Ferrer R, Morforte R, Garnacho A, Torres A, (2006) Risk and prognostic factors of ventilator-associated pneumonia in trauma patients. Crit Care Med 34: 1067-1072 32.Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, Wolff M, Spencer RC, Hemmer M, (1995) The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 274: 639-644 33.Fridkin SK, Gaynes RP, (1999) Antimicrobial resistance in intensive care units. Clin Chest Med 20: 303-316, viii 34.Williams RE, (1963) Healthy carriage of Staphylococcus aureus: its prevalence and importance. Bacteriol Rev 27: 56-71 35.Thompson RL, Cabezudo I, Wenzel RP, (1982) Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med 97: 309-317 36.Foster TJ, (2004) The Staphylococcus aureus "superbug". J Clin Invest 114: 1693-1696 37.Sista RR, Oda G, Barr J, (2004) Methicillin-resistant Staphylococcus aureus infections in ICU patients. Anesthesiol Clin North America 22: 405-435, vi 38.Huang YC, Hwang KP, Chen PY, Chen CJ, Lin TY, (2007) Prevalence of methicillin-resistant Staphylococcus aureus nasal colonization among Taiwanese children in 2005 and 2006. J Clin Microbiol 45: 3992-3995 39.Creech CB, 2nd, Kernodle DS, Alsentzer A, Wilson C, Edwards KM, (2005) Increasing rates of nasal carriage of methicillin-resistant Staphylococcus aureus in healthy children. Pediatr Infect Dis J 24: 617-621 40.Fredricks DN, (2001) Microbial ecology of human skin in health and disease. J Investig Dermatol Symp Proc 6: 167-169 41.Roth RR, James WD, (1988) Microbial ecology of the skin. Annu Rev Microbiol 42: 441-464 42.Pfaller MA, Herwaldt LA, (1988) Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci. Clin Microbiol Rev 1: 281-299 43.Richards MJ, Edwards JR, Culver DH, Gaynes RP, (1999) Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 27: 887-892 44.Streit JM, Jones RN, Sader HS, Fritsche TR, (2004) Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001). Int J Antimicrob Agents 24: 111-118 45.Hoban DJ, Biedenbach DJ, Mutnick AH, Jones RN, (2003) Pathogen of occurrence and susceptibility patterns associated with pneumonia in hospitalized patients in North America: results of the SENTRY Antimicrobial Surveillance Study (2000). Diagn Microbiol Infect Dis 45: 279-285 46.(2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171: 388-416 47.Connie R. Mahon GM (2000) Enterobacteriaceae. In: Connie R. Mahon GM (ed) Textbook of diagnostic microbiology. Saunders, Philadelphia, pp. 463-514 48.Halwani M, Solaymani-Dodaran M, Grundmann H, Coupland C, Slack R, (2006) Cross-transmission of nosocomial pathogens in an adult intensive care unit: incidence and risk factors. J Hosp Infect 63: 39-46 49.Grundmann H, Barwolff S, Tami A, Behnke M, Schwab F, Geffers C, Halle E, Gobel UB, Schiller R, Jonas D, Klare I, Weist K, Witte W, Beck-Beilecke K, Schumacher M, Ruden H, Gastmeier P, (2005) How many infections are caused by patient-to-patient transmission in intensive care units? Crit Care Med 33: 946-951 50.Selden R, Lee S, Wang WL, Bennett JV, Eickhoff TC, (1971) Nosocomial klebsiella infections: intestinal colonization as a reservoir. Ann Intern Med 74: 657-664 51.De Louvois J, (1969) Serotyping and the Dienes reaction on Proteus mirabilis from hospital infections. J Clin Pathol 22: 263-268 52.Beezhold DW, Slaughter S, Hayden MK, Matushek M, Nathan C, Trenholme GM, Weinstein RA, (1997) Skin colonization with vancomycin-resistant enterococci among hospitalized patients with bacteremia. Clin Infect Dis 24: 704-706 53.Gould IM, (2002) Antibiotic policies and control of resistance. Curr Opin Infect Dis 15: 395-400 54.Chow JW, Yu VL, Shlaes DM, (1994) Epidemiologic perspectives on Enterobacter for the infection control professional. Am J Infect Control 22: 195-201 55.Morris JG, Jr., Shay DK, Hebden JN, McCarter RJ, Jr., Perdue BE, Jarvis W, Johnson JA, Dowling TC, Polish LB, Schwalbe RS, (1995) Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center. Ann Intern Med 123: 250-259 56.Shlaes DM, Binczewski B, Rice LB, (1993) Emerging antimicrobial resistance and the immunocompromised host. Clin Infect Dis 17 Suppl 2: S527-536 57.Rello J, Ausina V, Ricart M, Castella J, Prats G, (1993) Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest 104: 1230-1235 58.Lucet JC, Paoletti X, Lolom I, Paugam-Burtz C, Trouillet JL, Timsit JF, Deblangy C, Andremont A, Regnier B, (2005) Successful long-term program for controlling methicillin-resistant Staphylococcus aureus in intensive care units. Intensive Care Med 31: 1051-1057 59.Blot SI, Vandewoude KH, Hoste EA, Colardyn FA, (2002) Effects of nosocomial candidemia on outcomes of critically ill patients. Am J Med 113: 480-485 60.Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Almodovar A, Jimenez-Jimenez FJ, Perez-Paredes C, Ortiz-Leyba C, (2003) Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med 31: 2742-2751 61.Harbarth S, Garbino J, Pugin J, Romand JA, Lew D, Pittet D, (2003) Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 115: 529-535 62.Heyland DK, Cook DJ, Griffith L, Keenan SP, Brun-Buisson C, (1999) The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med 159: 1249-1256 63.Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH, (2000) The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118: 146-155 64.Iregui M, Ward S, Sherman G, Fraser VJ, Kollef MH, (2002) Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 122: 262-268 65.Kollef MH, (2000) Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis 31 Suppl 4: S131-138 66.Tenover FC, (2006) Mechanisms of antimicrobial resistance in bacteria. Am J Med 119: S3-10; discussion S62-70 67.Tenover FC, McGowan JE, Jr., (1996) Reasons for the emergence of antibiotic resistance. Am J Med Sci 311: 9-16 68.Marshall C, Wesselingh S, McDonald M, Spelman D, (2004) Control of endemic MRSA-what is the evidence? A personal view. J Hosp Infect 56: 253-268 69.Monnet DL, (1998) Methicillin-resistant Staphylococcus aureus and its relationship to antimicrobial use: possible implications for control. Infect Control Hosp Epidemiol 19: 552-559 70.Muto CA, Jernigan JA, Ostrowsky BE, Richet HM, Jarvis WR, Boyce JM, Farr BM, (2003) SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol 24: 362-386 71.Kuo LC, Yu CJ, Kuo ML, Chen WN, Chang CK, Lin HI, Chen CC, Lu MC, Lin CH, Hsieh WF, Chen LW, Chou Y, Huang MS, Lee CH, Chen SC, Thai SL, Chen PC, Chen CH, Tseng CC, Chen YS, Hsiue TR, Hsueh PR, (2008) Antimicrobial resistance of bacterial isolates from respiratory care wards in Taiwan: a horizontal surveillance study. Int J Antimicrob Agents 31: 420-426
|